Should I Buy MTLS? MTLS 2026 Analysis

Should You Buy Materialise NV (MTLS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

5.510

1 Day change

6.78%

52 Week Range

9.690

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

["Not a good buy right now: momentum is bearish (negative, expanding MACD histogram) and price is trading below key pivot/resistance (Pivot ~5.51).", "While short-term mean-reversion bounce is possible (RSI_6 ~25.9 suggests oversold conditions), there is no Intellectia buy signal today, so the setup is not \u201chigh-conviction buy now\u201d for an impatient entry.", "Options positioning is skewed bullish (very low put/call open interest ratio), but volume is thin and implied volatility is elevated\u2014more consistent with uncertainty into earnings than a clean upside trend."]

Technical Analysis

["Trend/Momentum: MACD histogram = -0.0379 (below 0) and negatively expanding \u2192 bearish momentum is strengthening.", "RSI: RSI_6 = 25.901 \u2192 oversold/washed-out conditions; supports a possible short-term bounce, but does not override bearish momentum by itself.", "Moving averages: converging MAs \u2192 market is indecisive/transitioning, not confirming a durable uptrend yet.", "Key levels: Current 5.22 is below S1 ~5.278 and well below Pivot ~5.51. Near-term support: ~5.135 (S2). Resistance: ~5.51, then ~5.742 (R1).", "Intellectia Proprietary Trading Signals", "- AI Stock Picker: no signal on given stock today.", "- SwingMax: No signal on given stock recently."]

Options Data

Bearish

Technical Summary

Sell

Buy

Positive Catalysts

["Upcoming earnings event (calendar shows Q earnings 2026-02-23 pre-market; company news references Q4 2025 results and a management call) can act as a catalyst for a sharp upside move if results/guide surprise positively.", "Oversold technical condition (low RSI) increases odds of a short-term relief bounce if selling pressure fades.", "Options open interest skew favors calls (low put/call OI ratio), suggesting market participants are not heavily hedged for downside."]

Neutral/Negative Catalysts

["Bearish momentum is still strengthening (MACD histogram negative and expanding), increasing risk of continuation lower toward ~5.135 support.", "Earnings/event risk with elevated IV: pricing implies large move potential; without a clear directional edge, buying now is less attractive.", "No strong institutional/insider trend signals recently (hedge funds and insiders noted as neutral)."]

Financial Performance

["Latest reported quarter: 2025/Q3.", "Revenue: 66.259M, down -3.49% YoY \u2192 top-line contraction.", "Net income: 1.848M, down -39.31% YoY \u2192 profitability pressure.", "EPS: 0.03, down -40.00% YoY \u2192 earnings power weakening.", "Gross margin: 56.82%, down -0.73% YoY \u2192 slight margin compression."]

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

["No analyst rating or price-target change data was provided, so a clear Wall Street consensus trend cannot be confirmed from the dataset.", "Pros (typical bull view based on the company profile): exposure to 3D-printing software/medical device workflows and potential operating leverage if demand re-accelerates.", "Cons (typical bear view consistent with the latest quarter): shrinking revenue and sharply lower earnings suggest execution/macro headwinds and reduced near-term visibility."]

Analyst Rating

Wall Street analysts forecast MTLS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MTLS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy